HIGHLIGHTS
- who: TYPE and collaborators from the University of Hail, Saudi Arabia have published the Article: An updated pharmacological insight into calotropin as a potential therapeutic agent in cancer, in the Journal: (JOURNAL)
- how: The results showed that both doses of calotropin inhibit the efflux of Ca2+ via the Na+/Ca2+ exchanger. Together these data showed that calotropin inhibits tumor growth in colorectal cancer cells (Meng et_al 2016) .
SUMMARY
Due to the heterogeneity of cancers and their responses to treatment, major efforts are being made to improve existing therapeutic protocols or to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.